| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 29,527,552 | 25,914,238 | 22,476,322 | | Cost of Revenue | 12,612,022 | 11,422,046 | 9,815,147 | | | Gross Profit | 16,915,530 | 14,492,192 | 12,661,175 | | | Operating Expenses | | Research Development | 2,688,811 | 2,505,649 | 2,255,271 | | Selling General and Administrative | 8,435,624 | 7,407,998 | 6,349,685 | | Non Recurring | 97,256 |
-
| 2,014,000 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 5,693,839 | 4,578,545 | 2,042,219 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 571,924 | 484,245 | 174,512 | | Earnings Before Interest And Taxes | 6,384,760 | 5,062,790 | 2,692,542 | | Interest Expense | 528,474 | 593,142 | 416,172 | | Income Before Tax | 5,856,286 | 4,469,648 | 2,276,370 | | Income Tax Expense | 1,122,070 | 863,334 | 559,615 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,734,216 | 3,606,314 | 1,716,755 | | | Non-recurring Events | | Discontinued Operations | 146,503 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 4,880,719 | 3,606,314 | 1,716,755 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,880,719 | $3,606,314 | $1,716,755 |
|
0.15% Nasdaq 
Income Statement
